Design Therapeutics (DSGN) announced the appointment of Chris Storgard, M.D., as Chief Medical Officer. Most recently, Dr. Storgard served as CMO at ADARx Pharmaceuticals, where he transitioned ...

19:50 EDT Kazia Therapeutics (KZIA) trading halted, news pending Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for ...

In this article, we are going to take a look at where Summit Therapeutics Inc. (NASDAQ:SMMT) stands against other biotech stocks that dominate Monday’s top gainers. The stock market kicked off ...

JUPITER, Fla. and FREEHOLD, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (“Ligand”) (Nasdaq: LGND) and Channel Therapeutics ...

Tvardi Therapeutics, Inc. (Nasdaq: TVRD), a clinical-stage biopharmaceutical company developing novel STAT3 inhibitors for fibrosis-driven diseases, visits the Nasdaq MarketSite in Times Square.

Viking Therapeutics, Inc. (NASDAQ:VKTX) is gearing up to initiate a phase 3 study using its subcutaneous formulation of its candidate VK2735 for the treatment of patients with obesity. It is ...

Unfortunately, what's good news for Eli Lilly is probably bad news for investors in Novo Nordisk and Viking Therapeutics, both of which lag Lilly in the race to develop their own easy-to-take GLP ...

Across the recent three months, 4 analysts have shared their insights on Verve Therapeutics VERV, expressing a variety of opinions spanning from bullish to bearish. The following table ...

MANCHESTER, England, April 17, 2025 /PRNewswire/ -- Monument Therapeutics, a precision-neuroscience company focused on the development of innovative treatments for serious central nervous system ...

But its risk-reward profile now seems to justify a “Buy” rating. Verve Therapeutics is currently based in Cambridge, Massachusetts, and it's a clinical-stage biotech. Broadly speaking ...

Shares of Viking Therapeutics have sold off sharply as the market awaits updates on its drug candidates. The company is preparing for the possible FDA approval of its weight loss drug candidate ...

a mobile app developed by prescription digital medicines startup Click Therapeutics. The FDA marketing authorization announced Tuesday permits use of the Click digital therapeutic for the ...